# Minerva Controlled Evidence Intake Authorisation Phase Status v0.1

## Phase Summary

Minerva remains controlled-readiness only. The governed evidence intake phase, controlled evidence intake dry-run phase, authorisation gate, first-candidate selection, first-candidate review, and authorisation closeout are represented as deterministic local metadata.

## Progress Before Slice

Approximately 55-65% complete.

## Expected Progress After Slice

Approximately 90-100% complete.

## Work Added By This Slice

- First-candidate review service.
- Authorisation closeout service.
- Review and closeout tests.
- Evaluation docs for review, closeout, phase status, and next decision point.

## What Remains Deferred

Evidence ingestion, corpus mutation, Code Evidence ingestion, DB access/write, live retrieval, live LLM use, final natural-language answer generation, chat exposure, endpoint exposure, route registration, workforce-platform integration, analytics runtime integration, UI changes, deployment readiness, production readiness, and runtime readiness remain deferred.

## Quality Guardrails

Outputs are deterministic and side-effect free. Blocked claims produce blocked or review statuses. No service opens external connections, touches a database, mutates corpus, registers routes, or calls an LLM.

## Recommended Next Step

Choose the next decision point: explicitly authorise a future first no-mutation intake execution, run additional candidate review, create an external evidence summary catalogue, or keep Minerva paused.

## Developer Handoff

Treat this phase status as a control artefact. It is not an implementation signal for ingestion, runtime exposure, deployment, or production use.
